Company: CWAN
Filing Date: 2025-04-02
Form Type: 425
Source: 0001193125-25-071387
Chunk: 4

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-04-02
Form: 425
Chunk 4
---
 Clearwater’s directors and executive officers is available in Clearwater’s Annual Report on Form 10-Kfor the year ended December 31, 2024 filed with the SEC on February 26, 2025, the amendment to Clearwater’s Annual Report on Form 10-Kfor the year ended December 31, 2024 filed with the SEC on March 7, 2025, and in the Proxy Statement/Prospectus. Information about the directors and executive officers of Enfusion is available in its Annual Report on Form 10-Kfor the year ended December 31, 2024 filed with the SEC on March 3, 2025, its definitive proxy statement for its 2024 annual meeting of stockholders, which was filed with the SEC on April 26, 2024, and in the Proxy Statement/Prospectus. Other information regarding the participants in the solicitations and a description of their direct and indirect interests, by security holdings or otherwise, are or will be contained in the Proxy Statement/Prospectus and other relevant materials to be filed with the SEC regarding the Transaction when they become available. Investors should read the Proxy Statement/Prospectus carefully before making any voting or investment decisions. Copies of the documents filed with the SEC by Clearwater and Enfusion will be available free of charge through the website maintained by the SEC at www.sec.gov. Additionally, copies of documents filed with the SEC by Clearwater, including the Proxy Statement/Prospectus are available free of charge from Clearwater’s website at investors.clearwateranalytics.com/overview, and copies of documents filed with the SEC by Enfusion, including the Proxy Statement/Prospectus are available free of charge from Enfusion’s website at ir.enfusion.com.

| Item 9.01 | Financial Statements and Exhibits. |

(d): The following exhibits are being filed herewith:

| Exhibit 
 Number  
 99.1    |     | Description                                                                                                
 Joint Press Release, dated April 2, 2025, issued by Clearwater Analytics Holdings, Inc. and Enfusion, Inc. |
|:--------|:----|:-----------------------------------------------------------------------------------------------------------|
| 104     |     | Cover Page Interactive Data File (embedded within the Inline XBRL document)                                |

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

| Date: April 2,